Filters

Phase
    Intervention Type
      Status
        Location:
        LocationClose
        Distance
          Term Search
          You can select from the dropdown list OR enter your own terms to refine the search.

          Last Updated: 10/31/2025

          Need to find the closest trial?
          Sort By Distance
          Save trials for later
          Sign Up
          Not sure about your diagnosis?
          Check Your Symptoms
          1 clinical trial found

            An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)

            An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)

            Enrollment Status: Recruiting
            Publish Date: August 01, 2025
            Intervention Type: Drug
            Study Phase: Phase 3

            Summary: The purpose of this study is to evaluate the safety and tolerability of olezarsen in participants with SHTG.

            Showing 1-1 of 1

            Last Updated: 10/31/2025